About Somalogic
Somalogic is a company based in Boulder (United States) founded in 1999 was acquired by Illumina in June 2025.. Somalogic has raised $663.99 million across 20 funding rounds from investors including Société Générale, Illumina and Mitsui & Co.. The company has 319 employees as of December 31, 2022. Somalogic has completed 1 acquisition, including Palamedrix. Somalogic offers products and services including SomaScan Assay, SomaScan Platform, and SomaSignal Tests. Somalogic operates in a competitive market with competitors including Nautilus Biotechnology, Amunix, Biognosys, Elektrofi and ProteinSimple, among others.
- Headquarter Boulder, United States
- Employees 319 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Somalogic Operating Co., Inc.
-
Annual Revenue
$97.67 M20as on Dec 31, 2022
-
Net Profit
-
EBITDA
-
Total Equity Funding
$663.99 M (USD)
in 20 rounds
-
Latest Funding Round
$211.97 M (USD), Series E
Dec 23, 2020
-
Investors
Société Générale
& 26 more
-
Employee Count
319
as on Dec 31, 2022
- Investments & Acquisitions
-
Acquired by
Illumina
(Jun 23, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Somalogic
Somalogic offers a comprehensive portfolio of products and services, including SomaScan Assay, SomaScan Platform, and SomaSignal Tests. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
High-plex assay for measuring thousands of proteins from small samples.
Platform for discovery and validation in life sciences research.
Tests for identifying biomarkers in various diseases.
Unlock access to complete
Unlock access to complete
Funding Insights of Somalogic
Somalogic has successfully raised a total of $663.99M across 20 strategic funding rounds. The most recent funding activity was a Series E round of $211.97 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 20
- Last Round Series E — $212.0M
-
First Round
First Round
(09 Nov 2000)
- Investors Count 26
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2020 | Amount | Series E - Somalogic | Valuation | Janus Henderson Investors , Redmile Group |
|
| Nov, 2020 | Amount | Series E - Somalogic | Valuation | Casdin Capital | |
| Oct, 2020 | Amount | Grant - Somalogic | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Somalogic
Somalogic has secured backing from 27 investors, including venture fund and institutional investors. Prominent investors backing the company include Société Générale, Illumina and Mitsui & Co.. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Private equity fund focused on the biotechnology sector
|
Founded Year | Domain | Location | |
|
US-focused private equity and venture capital investments are managed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Somalogic
Somalogic has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Palamedrix. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of a multi-omics platform for therapeutics and diagnostics
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Somalogic
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Somalogic Comparisons
Competitors of Somalogic
Somalogic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nautilus Biotechnology, Amunix, Biognosys, Elektrofi and ProteinSimple, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A proteomics platform is developed for analyzing the human proteome.
|
|
| domain | founded_year | HQ Location |
Peptide-based therapeutics are developed for cancers and immune disorders.
|
|
| domain | founded_year | HQ Location |
Proteomics services are delivered via discovery and targeted platforms.
|
|
| domain | founded_year | HQ Location |
Digital platform transforming the delivery of biologic medicines
|
|
| domain | founded_year | HQ Location |
Provider tools to help researchers with protein analysis
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Somalogic
Frequently Asked Questions about Somalogic
When was Somalogic founded?
Somalogic was founded in 1999 and raised its 1st funding round 1 year after it was founded.
Where is Somalogic located?
Somalogic is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Is Somalogic a funded company?
Somalogic is a funded company, having raised a total of $663.99M across 20 funding rounds to date. The company's 1st funding round was a Grant of $1M, raised on Nov 09, 2000.
How many employees does Somalogic have?
As of Dec 31, 2022, the latest employee count at Somalogic is 319.
What is the annual revenue of Somalogic?
Annual revenue of Somalogic is $97.67M as on Dec 31, 2022.
What does Somalogic do?
Somalogic was founded in 1999 and is based in Boulder, United States. Operations focus on the biotechnology sector, where proprietary SOMAmer reagentsprotein-binding molecules akin to aptamers and antibodiesare utilized in the SOMAscan assay for measuring multiple proteins. The platform is provided as reagents and kits to researchers. Future plans include laboratory-developed tests from a CLIA-certified lab and therapeutics derived from SOMAmer technology.
Who are the top competitors of Somalogic?
Somalogic's top competitors include Nautilus Biotechnology, Elektrofi and Biognosys.
What products or services does Somalogic offer?
Somalogic offers SomaScan Assay, SomaScan Platform, and SomaSignal Tests.
How many acquisitions has Somalogic made?
Somalogic has made 1 acquisition, including Palamedrix.
Who are Somalogic's investors?
Somalogic has 27 investors. Key investors include Société Générale, Illumina, Mitsui & Co., Novartis, and Quest Diagnostics.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.